What is Stiolto Respimat?
Stiolto Respimat is a long-acting inhaler for people with chronic obstructive pulmonary disease (COPD). Itโs a maintenance treatment, which means you use it every day to help manage symptoms. It wonโt replace your rescue inhaler for sudden symptoms, but it can reduce how often you need to use one.[1]
Itโs often prescribed for people with moderate to very severe COPD, including chronic bronchitis and emphysema. Studies show that regular use can help to improve your day-to-day symptoms.[1]
How does Stiolto Respimat work for COPD?
Stiolto Respimat works by making it easier for air to move in and out of your lungs.
Stiolto combines two types of bronchodilators:
- Tiotropium, a long-acting muscarinic antagonist (LAMA), which blocks signals that cause airway muscles to tighten.
- Olodaterol, a long-acting beta2-agonist (LABA), which stimulates receptors in the lungs to help open up the airways.
Together, they relax and widen your airways, making it easier for you to breathe.
Will I get side effects using Stiolto Respimat?
Like all medications, side effects are possible with Stiolto, but they donโt affect everyone. The most common ones include a cough, runny nose, and back pain.
Some people might also feel nervous or have an increased heart rate or blood pressure, especially if you use too much. In some rare cases, it can cause more serious effects like eye pain, urinary retention, or allergic reactions. If anything feels off at all, stop using it and speak to a healthcare provider right away.
What doses of Stiolto Respimat are there?
Stiolto Respimat comes in a single fixed dose of 2.5mcg Tiotropium and 2.5mcg Olodaterol. Youโll typically take two puffs, once a day.
Treated trusted source:
- Ferguson, G.T., Karpel, J., et al. (2017). Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies. npj Primary Care Respiratory Medicine, 27(1), pp.1โ9.
How we source info.
When we present you with stats, data, opinion or a consensus, weโll tell you where this came from. And weโll only present data as clinically reliable if itโs come from a reputable source, such as a state or government-funded health body, a peer-reviewed medical journal, or a recognised analytics or data body. Read more in our editorial policy.